9572NomuGrowth
ALRAZI
شركة الرازي الطبية
Fair Value (median)
41.90 SAR
Current Price
30.96
Fair
Now
Undervalued
Discount +26.1%· upside +35.3%
Blended from: DCF · Graham
Health Check
49.1
Overall / 100
Value76.1
Future20
Past38
Health62.4
Dividend0
Value76.1/100
Trades about 26.1% below its estimated fair value.
- Discount to fair value
- 26.1%
- Price to book
- —
- Fair-value confidence
- —
Future20/100
Modest growth of about 8% a year is expected.
- Forecast growth (rev.)
- 8%
- Revenue CAGR (3y)
- 12.4%
- Earnings CAGR (3y)
- -25.9%
Past38/100
A steady, profitable operating history.
- Return on equity
- 3.5%
- Net margin
- 1.1%
- Earnings CAGR (3y)
- -25.9%
- Profitable years
- 4/4
Health62.4/100
Balance sheet is manageable.
- Debt to equity
- 50.7%
- Net debt to equity
- 49.4%
- Cash covers total debt
- No
- Free cash flow
- Positive
Dividend0/100
Pays no dividend.
- Dividend yield
- —
Rewards
- Trades 26.1% below estimated fair value.
Risks
—
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Dividend return (if you buy today)
This company doesn’t currently pay a dividend, so there’s no income return to project. The fair-value gauge above covers the price side.
Historical Wealth Simulator
Invest a fixed amount every year and see what it would be worth today.
If you invested 1,000.00 annually starting 2023، your value today is 2,775.87. You put in 4,000.00 over 4 years. Total return: -30.6% (+1.5% Dividends، -32.1% Capital gain).
Invested
4,000.00 SAR
Dividends
61.85 SAR
Capital gain
-1,285.98 SAR
InvestedCapital gainDividends— dashes = cost basistap a bar for figures
Split-adjusted prices; dividends taken as cash (not reinvested). Past performance isn’t a forecast.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Valuation breakdown
Fair value = median of the applicable methods (DCF، Graham).
Discounted Cash Flow
Tap to adjust assumptions
70.10 SAR
Dividend Discount Model
Excluded — company pays no dividend
N/A
Graham Number
Tap to adjust assumptions
13.69 SAR
Fair Value (median)41.90 SAR
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 7.18%
- CAPM cost of equity
- 7.18%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Dividend history
Dividend / share & historical yield (SAR).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · SAR
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — |
| 2023 | 0.40 | 0.40 | 0.40 | 0.40 | 1.59 | 2.4% |
| 2022 | — | — | — | — | — | — |
Key figures
| Metric | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|
| Revenue | 52.39M | 61.33M | 61.35M | 74.38M |
| Net Income | 2.01M | 686.0K | 175.9K | 819.5K |
| Net Margin | 3.8% | 1.1% | 0.3% | 1.1% |
| Operating Cash Flow | 2.05M | 5.78M | 4.96M | 5.82M |
| OCF Margin | 3.9% | 9.4% | 8.1% | 7.8% |
| Capital Expenditure | 0 | 5.07M | 3.87M | 1.98M |
| Free Cash Flow | 2.05M | 709.8K | 1.09M | 3.84M |
| FCF Margin | 3.9% | 1.2% | 1.8% | 5.2% |
| FCF Conversion | 101.9% | 103.5% | 619.7% | 469.0% |
| EPS (Diluted) | 1.33 | 0.45 | 0.12 | 0.54 |
| Dividend / Share | 0.00 | 1.59 | 0.00 | 0.00 |
Corporate actions
DCash Dividend
0.39 SAR /sh2023-09-05
Community Notes0
No notes yet. Be the first to share a thesis.